Print

Inimex Pharmaceuticals Inc. Receives Additional $1.7M To Cap Series A Round At $6.7M 
10/19/2005 5:12:23 PM

After securing C$6 million from a group of Canadian investors for the first part of its Series A financing in June, Vancouver-based biotech start-up Inimex Pharmaceuticals Inc. closed an additional C$2 million ($1.7 million) to cap the round at C$8 million ($6.7 million).
//-->